Type 2 diabetes mellitus and cardiovascular risk; what the pharmacotherapy can change through the epigenetics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Type 2 diabetes mellitus and cardiovascular risk; what the pharmacotherapy can change through the epigenetics

Published:2019-10-29 Issue:2 Volume:132 Page:109-125
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Andreeva–Gateva Pavlina A.¹²^ORCID,Mihaleva Ivelina D.¹,Dimova Ivanka I.³

Affiliation:

1. Department of Pharmacology and Toxicology, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria

2. Department of Pharmacology, Medical Faculty, Sofia University “St Kliment Ohridski”, Sofia, Bulgaria

3. Department of Medical Genetics, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2019.1681215

Reference165 articles.

1. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

2. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis

3. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

4. Management of Comorbid Diabetes Mellitus and Worsening Heart Failure

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diallyl Trisulfide and Cardiovascular Health: Evidence and Potential Molecular Mechanisms;International Journal of Molecular Sciences;2024-09-11

2. Synergistic therapeutic strategies and engineered nanoparticles for anti-vascular endothelial growth factor therapy in cancer;Life Sciences;2024-03

3. Role of Epigenetics and Metabolomics in Predicting Endothelial Dysfunction in Type 2 Diabetes;Advanced Biology;2023-08-24

4. Cardiotrophin-1 as a prognostic biomarker of hypertension and a key regulator of cardiac glucose metabolism;INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine);2023-04-29

5. The Potential Role of Gut Microbiota in the Pathogenesis of Type 2 Diabetes Mellitus via Epigenetics and Inflammasome;Endocrine, Metabolic & Immune Disorders - Drug Targets;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3